Advanced search
Publication Cover
Leukemia & Lymphoma Volume 47, 2006 - Issue 7
Submit an article Journal homepage
284
Views
51
CrossRef citations to date
0
Altmetric
Original

First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy ± radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma

Keun-wook Lee Department of Internal Medicine, Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
,
Tak Yun Department of Internal Medicine, Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
,
Dong-wan Kim Department of Internal Medicine, Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
,
Seock-ah Im Department of Internal Medicine, Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
,
Tae-you Kim Department of Internal Medicine, Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
,
Sung-soo Yoon Department of Internal Medicine, Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
,
Professor Dae Seog Heo Department of Internal Medicine, Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, KoreaCorrespondence[email protected]
,
Yung-jue Bang Department of Internal Medicine, Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
,
Seonyang Park Department of Internal Medicine, Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
,
Byoung Kook Kim Department of Internal Medicine, Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
&
Noe Kyeong Kim Department of Internal Medicine, Cancer Research Institute, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
 show all
Pages 1274-1282 | Received 25 Aug 2005, Accepted 21 Nov 2005, Published online: 01 Jul 2009

Citations (51)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (13)

Jin Li, Yajun Li, Ruolan Zeng, Jingguan Lin, Meizuo Zhong, Xianling Liu, Yizi He, Junqiao He, Zhou Ouyang, Lijun Huang, Ling Xiao & Hui Zhou. (2020) Optimal Courses of Chemotherapy Combined with Radiotherapy for Low-Risk Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Propensity Score Matching Analysis. Therapeutics and Clinical Risk Management 16, pages 1151-1163.
Read now
Masanori Yoshida, Tomoo Osumi, Ken-Ichi Imadome, Daisuke Tomizawa, Motohiro Kato, Noritaka Miyazawa, Reiko Ito, Atsuko Nakazawa & Kimikazu Matsumoto. (2018) Successful treatment of systemic EBV positive T-cell lymphoma of childhood using the SMILE regimen. Pediatric Hematology and Oncology 35:2, pages 121-124.
Read now
Li-Hua Dong, Li-Juan Zhang, Wen-Jia Wang, Wen Lei, Xing Sun, Jian-Wei Du, Xue Gao, Gang-Ping Li & Yu-Fu Li. (2016) Sequential DICE combined with l-asparaginase chemotherapy followed by involved field radiation in newly diagnosed, stage IE to IIE, nasal and extranodal NK/T-cell lymphoma. Leukemia & Lymphoma 57:7, pages 1600-1606.
Read now
Wook Youn Kim, Soo Jeong Nam, Sehui Kim, Tae Min Kim, Dae Seog Heo, Chul-Woo Kim & Yoon Kyung Jeon. (2015) Prognostic implications of CD30 expression in extranodal natural killer/T-cell lymphoma according to treatment modalities. Leukemia & Lymphoma 56:6, pages 1778-1786.
Read now
Jie Ji, Ting Liu, Bing Xiang, Weiping Liu, Chuan He, Xinchuan Chen, Jianjun Li, Hong Chang, Yang Dai & Tian Dong. (2014) A study of gemcitabine, l-asparaginase, ifosfamide, dexamethasone and etoposide chemotherapy for newly diagnosed stage IV, relapsed or refractory extranodal natural killer/T-cell lymphoma, nasal type. Leukemia & Lymphoma 55:12, pages 2955-2957.
Read now
Shu-Nan Qi, Ye-Xiong Li, Wei-Hu Wang, Jing Jin, Shu-Lian Wang, Yue-Ping Liu, Yong-Wen Song, Hui Fang, Hua Ren, Ning-Ning Lu, Qing-Feng Liu, Run-Ye Wu, Xi-Mei Zhang, Xin-Fan Liu & Zi-Hao Yu. (2012) The extent of cutaneous lesions predicts outcome in extranodal nasal-type natural killer/T-cell lymphoma of the upper aerodigestive tract with secondary cutaneous involvement. Leukemia & Lymphoma 53:5, pages 855-861.
Read now
Fumihiro Ishida & Yok-Lam Kwong. (2010) Diagnosis and management of natural killer-cell malignancies. Expert Review of Hematology 3:5, pages 593-602.
Read now
Holbrook Kohrt, Mark Lee & Ranjana Advani. (2010) Risk stratification in extranodal natural killer/T-cell lymphoma. Expert Review of Anticancer Therapy 10:9, pages 1395-1405.
Read now
Daichi Inoue, Yuya Nagai, Yoko Takiuchi, Seiji Nagano, Hiroshi Arima, Takaharu Kimura, Sonoko Shimoji, Minako Mori, Katsuhiro Togami, Sumie Tabata, Soshi Yanagita, Akiko Matsushita, Kenichi Nagai, Hayato Maruoka, Yukihiro Imai, Ritsuro Suzuki & Takayuki Takahashi. (2010) Successful treatment of extranodal natural killer/T-cell lymphoma, nasal type, complicated by severe hemophagocytic syndrome, with dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide chemotherapy followed by autologous stem cell transplant. Leukemia & Lymphoma 51:4, pages 720-723.
Read now
Holbrook Kohrt & Ranjana Advani. (2009) Extranodal natural killer/T-cell lymphoma: current concepts in biology and treatment. Leukemia & Lymphoma 50:11, pages 1773-1784.
Read now
Ravindran Kanesvaran, Miriam Tao, Iain Tan Bee Huat, Daniel Tan Shao Weng, David Ng Chee Eng & Lim Soon Thye. (2009) Malignant arrhythmia: A case report of nasal NK/T-cell lymphoma with cardiac involvement. Acta Oncologica 48:4, pages 637-639.
Read now
Susan Li Er Loong, Jacqueline Siok Gek Hwang, Soon-thye Lim, Swee Peng Yap, Miriam Tao, Tsung-wen Chong, Leonard Hwan Cheong Tan & Hung Huynh. (2008) An Epstein-Barr virus positive natural killer lymphoma xenograft derived for drug testing. Leukemia & Lymphoma 49:6, pages 1161-1167.
Read now
Agustin Avilés, Sergio Cleto, Claudia Castañeda & Maria Jesús Nambo. (2007) CMED in the treatment of nasal natural killer cell lymphoma with distant metastases. Hematology 12:3, pages 241-244.
Read now

Articles from other publishers (38)

Zheng Yan, Shuna Yao, Zhizhong Wang, Wenping Zhou, Zhihua Yao & Yanyan Liu. (2023) Treatment of extranodal NK/T-cell lymphoma: From past to future. Frontiers in Immunology 14.
Crossref
Vikram Sumbly, Mallorie Vest & Ian Landry. (2022) Aggressive Natural Killer Cell Leukemia: A Brief Overview of Its Genomic Landscape, Histological Features, and Current Management. Cureus.
Crossref
Jian Li, Juxin Ye, Yongren Wang, Jun Wang & Yongjun Fang. (2021) Successful treatment by using a modified SMILE regimen and autologous hematopoietic stem cell transplantation in a pediatric primary EBV-positive nodular NK/T cell lymphoma patient. Annals of Hematology 101:2, pages 433-435.
Crossref
Hayder Saeed & Lubomir Sokol. (2021) Extranodal NK/T Cell Lymphoma: Evidence-based Review of Safety and Toxicity of the Available Regimens. Clinical Lymphoma Myeloma and Leukemia 21:4, pages 199-204.
Crossref
Li Jiang, Pengfei Li, Qi Quan, Ping Chen, Huijuan Qiu & Bei Zhang. (2020) Cutaneous extranodal natural killer (NK) / T - cell lymphoma: A comprehensive clinical features and outcomes analysis of 71 cases. Leukemia Research 88, pages 106284.
Crossref
Dok Hyun Yoon, Seok Jin Kim, Seong Hyun Jeong, Dong-Yeop Shin, Sung Hwa Bae, Junshik Hong, Seong Kyu Park, Ho-Young Yhim, Deok-Hwan Yang, Hyewon Lee, Hye Jin Kang, Mark Hong Lee, Hyeon-Seok Eom, Jae-Yong Kwak, Jae Hoon Lee, Cheolwon Suh & Won Seog Kim. (2016) Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I/II extranodal NK/T-cell lymphoma, nasal type (CISL-1008). Oncotarget 7:51.
Crossref
Xin Li, Yingying Cui, Zhenchang Sun, Lei Zhang, Ling Li, Xinhua Wang, Jingjing Wu, Xiaorui Fu, Wang Ma, Xudong Zhang, Yu Chang, Feifei Nan, Wencai Li, Liping Su, Jinghua Wang, Hongwei Xue & Mingzhi Zhang. (2016) DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China. Clinical Cancer Research 22:21, pages 5223-5228.
Crossref
Ji Young LeeSang Min LeeMoon Young ChoiKi Hyang KimYoung Don JooSung Nam ImWon Sik Lee. (2016) Treatment outcomes of IMEP as a front-line chemotherapy for patients with peripheral T-cell lymphomas. Blood Research 51:3, pages 187.
Crossref
Seha Park, Junshik Hong, Incheol Hwang, Jeong-Yeal Ahn, Eun Yeong Cho, Jinny Park, Eun Kyung Cho, Dong Bok Shin & Jae Hoon Lee. (2015) Comprehensive geriatric assessment in elderly patients with newly diagnosed aggressive non-Hodgkin lymphoma treated with multi-agent chemotherapy. Journal of Geriatric Oncology 6:6, pages 470-478.
Crossref
Miso Kim, Tae Min Kim, Ki Hwan Kim, Bhumsuk Keam, Se-Hoon Lee, Dong-Wan Kim, Jong Seok Lee, Yoon Kyung Jeon, Chul Woo Kim & Dae Seog Heo. (2014) Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus l-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL). Annals of Hematology 94:3, pages 437-444.
Crossref
F.-G. Riet, C.-H. Canova, J. Gabarre, S. Ben Hassine, L. Kamsu Kom, J.-J. Mazeron & L. Feuvret. (2014) Radiothérapie des lymphomes NK/T localisés aux fosses nasales. Cancer/Radiothérapie 18:2, pages 147-153.
Crossref
Li Yang, Hong Liu, Xiao-hong Xu, Xin-feng Wang, Hong-ming Huang, Wen-yu Shi & Sheng-hua Jiang. (2013) Retrospective study of modified SMILE chemotherapy for advanced-stage, relapsed, or refractory extranodal natural killer (NK)/T cell lymphoma, nasal type. Medical Oncology 30:4.
Crossref
Andrei Shustov. (2013) Novel therapies for peripheral T-cell lymphomas. Therapeutic Advances in Hematology 4:3, pages 173-187.
Crossref
Mei Dong, Xiao-hui He, Peng Liu, Yan Qin, Jian-liang Yang, Sheng-yu Zhou, Sheng Yang, Chang-gong Zhang, Lin Gui, Li-qiang Zhou & Yuan-kai Shi. (2012) Gemcitabine-based combination regimen in patients with peripheral T-cell lymphoma. Medical Oncology 30:1.
Crossref
Ting Zhao, Ye-Xiong Li, Shu-Lian Wang, Jing Jin, Wei-Hu Wang, Yong-Wen Song, Yue-Ping Liu, Xin-Fan Liu, Hui Fang, Hua Ren, Bo Chen, Shu-Nan Qi, Qing-Feng Liu, Ning-Ning Lu & Zi-Hao Yu. (2012) Survival benefit with salvage radiotherapy for patients with locoregionally recurrent extranodal NK/T cell lymphoma, nasal type. Annals of Hematology 92:3, pages 325-332.
Crossref
Jieun LeeChul Yong KimYoung Je ParkNam Kwon Lee. (2013) Sequential chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in patients with stage I/II extranodal natural killer/T-cell lymphoma, nasal type. Blood Research 48:4, pages 274.
Crossref
Motoko Yamaguchi & Kensei Tobinai. 2013. T-Cell Lymphomas. T-Cell Lymphomas 87 103 .
Francine M. Foss. 2013. Non-Hodgkin Lymphoma. Non-Hodgkin Lymphoma 213 237 .
H.K. Ahn, C. Suh, S.S. Chuang, J. Suzumiya, Y.H. Ko, S.J. Kim, J.R. Huh, D.H. Yoon, S.Y. Oh, J.S. Kim, S.I. Lee, K.W. Park, P.P. Hsieh, S. Nakamura, T. Yoshino, K. Ito, T. Nagatani, K. Oshimi, R. Suzuki & W.S. Kim. (2012) Extranodal natural killer/T-cell lymphoma from skin or soft tissue: suggestion of treatment from multinational retrospective analysis. Annals of Oncology 23:10, pages 2703-2707.
Crossref
Ye-Xiong Li, Hua Wang, Jing Jin, Wei-Hu Wang, Qing-Feng Liu, Yong-Wen Song, Zhao-Yang Wang, Shu-Nan Qi, Shu-Lian Wang, Yue-Ping Liu, Xin-Fan Liu & Zi-Hao Yu. (2012) Radiotherapy Alone With Curative Intent in Patients With Stage I Extranodal Nasal-Type NK/T-Cell Lymphoma. International Journal of Radiation Oncology*Biology*Physics 82:5, pages 1809-1815.
Crossref
Ye‐Xiong Li, Qing‐Feng Liu, Wei‐Hu Wang, Jing Jin, Yong‐Wen Song, Shu‐Lian Wang, Yue‐Ping Liu, Xin‐Fan Liu, Li‐Qiang Zhou & Zi‐Hao Yu. (2011) Failure patterns and clinical implications in early stage nasal natural killer/T‐cell lymphoma treated with primary radiotherapy. Cancer 117:22, pages 5203-5211.
Crossref
Francine Foss. (2011) Evolving therapy of peripheral T-cell lymphoma: 2010 and beyond. Therapeutic Advances in Hematology 2:3, pages 161-173.
Crossref
Young-Wook ParkYong-Tae ParkKyo-Hee ChoiSeong-Gon Kim. (2011) Relapsed extranodal NK/T-cell lymphoma in the mandible, Nasal Type: a case report and review of the literatures. Journal of the Korean Association of Oral and Maxillofacial Surgeons 37:4, pages 329.
Crossref
Seok Jin Kim & Won Seog Kim. (2010) Treatment of localized extranodal NK/T cell lymphoma, nasal type. International Journal of Hematology 92:5, pages 690-696.
Crossref
Matthew J. Matasar & Steven M. Horwitz. 2011. Management of Hematologic Malignancies. Management of Hematologic Malignancies 410 431 .
Hui-Hui Ma, Li-Ting Qian, Hai-Feng Pan, Lin Yang, Hong-Yan Zhang, Zhi-Hua Wang, Jun Ma, Yu-Fei Zhao, Jin Gao & Ai-Dong Wu. (2009) Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphoma. Medical Oncology 27:3, pages 798-806.
Crossref
Francine M. Foss. (2010) Enhancing Existing Approaches to Peripheral T-Cell Lymphoma. Seminars in Hematology 47, pages S8-S10.
Crossref
Tae Min Kim & Dae Seog Heo. (2009) Extranodal NK / T‐cell lymphoma, nasal type: New staging system and treatment strategies. Cancer Science 100:12, pages 2242-2248.
Crossref
Xuejun Ma, Ye Guo, Ziqiang Pang, Biyun Wang, Hongfen Lu, Ya-Jia Gu & Xiaomao Guo. (2009) A randomized phase II study of CEOP with or without semustine as induction chemotherapy in patients with stage IE/IIE extranodal NK/T-cell lymphoma, nasal type in the upper aerodigestive tract. Radiotherapy and Oncology 93:3, pages 492-497.
Crossref
Motoko YamaguchiKensei TobinaiMasahiko OguchiNaoki IshizukaYukio KobayashiYasushi IsobeKenichi IshizawaNobuo MasekiKuniaki ItohNoriko UsuiIzumi WasadaTomohiro KinoshitaKoichi OhshimaYoshihiro MatsunoTakashi TerauchiShigeru NawanoSatoshi IshikuraYoshikazu KagamiTomomitsu HottaKazuo Oshimi. (2009) Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211. Journal of Clinical Oncology 27:33, pages 5594-5600.
Crossref
Wing-yan AuDennis D. WeisenburgerTanin IntragumtornchaiShigeo NakamuraWon-Seog Kim, Ivy Sng, Julie VoseJames O. ArmitageRaymond Liang. (2009) Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood 113:17, pages 3931-3937.
Crossref
B.-S. Kim, D.-W. Kim, S.-A. Im, C.W. Kim, T.-Y. Kim, S.-S. Yoon, D.S. Heo, Y.-J. Bang, S. Park, B.K. Kim & N.K. Kim. (2009) Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone. Annals of Oncology 20:1, pages 121-128.
Crossref
A. Jaccard, B. Petit, S. Girault, F. Suarez, R. Gressin, J.-M. Zini, V. Coiteux, C. Larroche, A. Devidas, C. Thiéblemont, P. Gaulard, B. Marin, N. Gachard, D. Bordessoule & O. Hermine. (2009) L-Asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature. Annals of Oncology 20:1, pages 110-116.
Crossref
Biyun Wang, Xiao‐Qiu Li, Xuejun Ma, Xiaonan Hong, Hongfen Lu & Ye Guo. (2008) Immunohistochemical expression and clinical significance of P‐glycoprotein in previously untreated extranodal NK/T‐cell lymphoma, nasal type. American Journal of Hematology 83:10, pages 795-799.
Crossref
Motoko Yamaguchi, Ritsuro Suzuki, Yok-Lam Kwong, Won Seog Kim, Yuichi Hasegawa, Koji Izutsu, Junji Suzumiya, Takayuki Okamura, Shigeo Nakamura, Keisei Kawa & Kazuo Oshimi. (2008) Phase I study of dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia. Cancer Science 99:5, pages 1016-1020.
Crossref
Yexiong Li & Jiade J. Lu. 2008. Radiation Oncology. Radiation Oncology 445 460 .
Kazuo Oshimi. (2007) Progress in understanding and managing natural killer-cell malignancies. British Journal of Haematology 139:4, pages 532-544.
Crossref
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:2, pages 98-105.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.